Presenting clinical and laboratory characteristics of patients with cHD
. | BCL-2 expression . | P* . | |||
---|---|---|---|---|---|
Known . | Unknown . | ||||
No. . | % . | No. . | % . | ||
All patients | 707 | 100 | 988 | 100 | |
Age, y | |||||
Median | 31 | NA | 30 | NA | .8† |
Range | 4-88 | NA | 5-82 | NA | |
Male sex | 383 | 54 | 540 | 55 | .8 |
B symptoms | 258/707 | 36 | 362/985 | 37 | .9 |
Histology | |||||
Nodular sclerosis | 551 | 78 | 680 | 69 | |
Mixed cellularity | 143 | 20 | 239 | 24 | |
Lymphocyte depletion | 5 | 1 | 15 | 2 | |
Lymphocyte-rich cHD | 0 | 0 | 3 | 0.3 | |
cHD not further classified | 8 | 1 | 51 | 5 | |
Ann Arbor stage | .6‡ | ||||
I | 94 | 13 | 156 | 16 | |
II | 358 | 51 | 482 | 49 | |
III | 142 | 20 | 196 | 20 | |
IV | 113 | 16 | 154 | 16 | |
High serum LDH level | 213/627 | 34 | 204/650 | 31 | .3 |
High serum β2-microglobulin level | 161/434 | 37 | 148/483 | 31 | .04 |
Bone marrow involvement | 55/707 | 8 | 55/983 | 6 | .09 |
Inguinal or iliac node involvement | 131/705 | 19 | 165/966 | 17 | .4 |
Mediastinal mass ratio at least 0.45 | 77/502 | 15 | 70/434 | 16 | .8 |
Low serum albumin level | 96/648 | 15 | 141/782 | 18 | .1 |
Anemia | 313/702 | 45 | 469/968 | 48 | .1 |
Leukocytosis | 67/702 | 10 | 116/963 | 12 | .1 |
Lymphocytopenia | 181/637 | 28 | 216/863 | 25 | .2 |
. | BCL-2 expression . | P* . | |||
---|---|---|---|---|---|
Known . | Unknown . | ||||
No. . | % . | No. . | % . | ||
All patients | 707 | 100 | 988 | 100 | |
Age, y | |||||
Median | 31 | NA | 30 | NA | .8† |
Range | 4-88 | NA | 5-82 | NA | |
Male sex | 383 | 54 | 540 | 55 | .8 |
B symptoms | 258/707 | 36 | 362/985 | 37 | .9 |
Histology | |||||
Nodular sclerosis | 551 | 78 | 680 | 69 | |
Mixed cellularity | 143 | 20 | 239 | 24 | |
Lymphocyte depletion | 5 | 1 | 15 | 2 | |
Lymphocyte-rich cHD | 0 | 0 | 3 | 0.3 | |
cHD not further classified | 8 | 1 | 51 | 5 | |
Ann Arbor stage | .6‡ | ||||
I | 94 | 13 | 156 | 16 | |
II | 358 | 51 | 482 | 49 | |
III | 142 | 20 | 196 | 20 | |
IV | 113 | 16 | 154 | 16 | |
High serum LDH level | 213/627 | 34 | 204/650 | 31 | .3 |
High serum β2-microglobulin level | 161/434 | 37 | 148/483 | 31 | .04 |
Bone marrow involvement | 55/707 | 8 | 55/983 | 6 | .09 |
Inguinal or iliac node involvement | 131/705 | 19 | 165/966 | 17 | .4 |
Mediastinal mass ratio at least 0.45 | 77/502 | 15 | 70/434 | 16 | .8 |
Low serum albumin level | 96/648 | 15 | 141/782 | 18 | .1 |
Anemia | 313/702 | 45 | 469/968 | 48 | .1 |
Leukocytosis | 67/702 | 10 | 116/963 | 12 | .1 |
Lymphocytopenia | 181/637 | 28 | 216/863 | 25 | .2 |